Mr Daniel Winschel, PA | |
444 W Fort St Fl 2, Boise, ID 83702-4535 | |
(208) 422-1018 | |
Not Available |
Full Name | Mr Daniel Winschel |
---|---|
Gender | Male |
Speciality | Physician Assistant - Surgical |
Location | 444 W Fort St Fl 2, Boise, Idaho |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508843038 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 1073 (Massachusetts) | Secondary |
363AS0400X | Physician Assistant - Surgical | 1073 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Daniel Winschel, PA 444 W Fort St Fl 2, Boise, ID 83702-4535 Ph: (208) 422-1018 | Mr Daniel Winschel, PA 444 W Fort St Fl 2, Boise, ID 83702-4535 Ph: (208) 422-1018 |
News Archive
Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.
Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces the opening of a new physical therapy clinic in Silver Spring, MD.
"Insurance companies rack up much higher profits on health coverage sold to nearly 100,000 Massachusetts college students than on plans available to the general public, according to long-awaited data released late yesterday by the state," The Boston Globe reports.
Taking a break in the middle of your workout may metabolize more fat than exercising without stopping, according to a recent study in Japan.
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology.
› Verified 8 days ago